NCT00733642View on ClinicalTrials.gov

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

PF-04360365 1 mg/kg

PF-04360365 1 mg/kg infused as a single dose

BIOLOGICAL

PF-04360365 3 mg/kg

PF-04360365 3 mg/kg infused as a single dose

BIOLOGICAL

PF-04360365 5 mg/kg

PF-04360365 5 mg/kg infused as a single dose

BIOLOGICAL

PF-04360365 10 mg/kg

PF-04360365 10 mg/kg infused as a single dose

Trial Locations (3)

91206

Pfizer Investigational Site, Glendale

07724

Pfizer Investigational Site, Eatontown

07755

Pfizer Investigational Site, Oakhurst

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY